- Lobbying
- Tyler AND McIntosh
Lobbying Arrangements Results for 'Tyler Mc Intosh'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Policy issues relating to federal healthcare regulatory and reimbursement matters. |
Yamo Pharmaceuticals, LLC
|
BAKER & HOSTETLER LLP | |||
Details Regulatory and reimbursement policy issues related to federal healthcare programs, including Medicare and Medicaid. |
Insmed Incorporated
|
BAKER & HOSTETLER LLP | |||
Details Policy issues relating to Medicare inpatient and outpatient reimbursement, including the New Technology Add-on Payment program. |
Gilead Sciences, Inc.
|
BAKER & HOSTETLER LLP | |||
Details Regulatory and reimbursement policy issues related to federal healthcare programs, including Medicare and Medicaid. |
Strongbridge Biopharma, PLC
|
BAKER & HOSTETLER LLP | |||
Details Policy issues related to Public Law 112-144, the Food and Drug Administration Safety and Innovation Act |
Genentech, Inc.
|
BAKER & HOSTETLER LLP | |||
Details Policy issues including regulatory and payment matters relating to aneurysmal and subarachnoid hemorrhage; HR 1648, the Ellie Helton, Lisa Colagrossi, Teresa Anne Lawrence, and Jennifer Sedney Focu... |
Edge Therapeutics, Inc.
|
BAKER & HOSTETLER LLP | |||
Details Reimbursement issues for biotechnology manufacturers, including Medicare Part B |
Ophthotech Corp.
|
BAKER & HOSTETLER LLP | |||
Details Regulatory and reimbursement policy issues related to federal healthcare programs, including Medicare and Medicaid. |
UroGen Pharma Ltd.
|
BAKER & HOSTETLER LLP | |||
Details Regulatory and reimbursement issues relating to pharmaceutical products. |
Depomed Inc.
|
BAKER & HOSTETLER LLP | |||
Details Regulatory and payment issues relating to medical technology manufacturers. |
Integra LifeSciences Corp.
|
BAKER & HOSTETLER LLP | |||
Details Regulatory and reimbursement policy issues related to federal healthcare programs, including Medicare and Medicaid. |
Tyme Technologies, Inc.
|
BAKER & HOSTETLER LLP | |||
Details Policy issues related to outsourcing facilities as defined under Sec. 503B of Public Law No. 113-54, the Drug Quality and Security Act. |
Outsourcing Facilities Association
|
BAKER & HOSTETLER LLP | |||
Details Policy issues regarding healthcare research, including federal funding. |
Southern Research
|
BAKER & HOSTETLER LLP | |||
Details Healthcare policy; Medicare Part B. and essential health benefits requirements of Public Law 111-148, the Affordable Care Act; H.R. 1628, American Health Care Act |
Aeroflow Healthcare
|
BAKER & HOSTETLER LLP | |||
Details Regulatory and reimbursement policy issues related to federal healthcare programs, including Medicare and Medicaid. |
Hill-Rom Holdings
|
BAKER & HOSTETLER LLP | |||
Details H.R. 34, the 21st Century Cures Act H.R. 512, the Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act S. 145, the Promise for Antibiotics and Therapeutics for Health Ac... |
The Medicines Company
|
BAKER & HOSTETLER LLP | |||
Details Policy issues relating to the chemistry industry, including the deployment of plastic piping in infrastructure projects. Policy issues relating to tax reform. |
American Chemistry Council
|
BAKER & HOSTETLER LLP | |||
Details Regulatory and reimbursement policy issues related to federal healthcare programs, including Medicare and Medicaid. |
Cardinal Health, Inc.
|
BAKER & HOSTETLER LLP | |||
Details Regulatory and reimbursement policy issues related to federal healthcare programs, including Medicare and Medicaid. |
Gamida
|
BAKER & HOSTETLER LLP | |||
Details Policy issues related to Public Law 114-225, the 21st Century Cures Act, specifically related to FDA staffing Policy issues related to Public Law 112-144, the Food and Drug Administration Safety a... |
Portola Pharmaceuticals Inc.
|
BAKER & HOSTETLER LLP | |||
Details Policy issues related to Public Law 114-225, the 21st Century Cures Act, specifically related to combination pharmaceutical products. |
Aralez Pharmaceuticals US, Inc.
|
BAKER & HOSTETLER LLP | |||
Details Policy issues related to Public Law 112-144, the Food and Drug Administration Safety and Innovation Act, specifically Section 902 related to the Breakthrough Therapy Designation for pharmaceuticals... |
Advaxis, Inc.
|
BAKER & HOSTETLER LLP | |||
Details Regulatory and reimbursement policy issues related to federal healthcare programs, including Medicare and Medicaid. |
Biotechnology Innovation Organization
|
BAKER & HOSTETLER LLP | |||
Details Regulatory and reimbursement policy issues related to federal healthcare programs, including Medicare and Medicaid. |
Becton, Dickinson and Company
|
BAKER & HOSTETLER LLP | |||
Details Regulatory and reimbursement policy issues impacting medical device and technology manufacturers related to federal healthcare programs, including Medicare and Medicaid, and issues related to safe ... |
Baxter Healthcare Corporation
|
BAKER & HOSTETLER LLP | |||
Details Regulatory and reimbursement policy issues related to federal healthcare programs associated with gene therapy and oncology treatments. |
Ferring Pharmaceuticals, Inc.
|
BAKER & HOSTETLER LLP | |||
Details Regulatory and reimbursement policy issues related to federal healthcare programs, including Medicare and Medicaid. |
AbbVie, Inc.
|
BAKER & HOSTETLER LLP | |||
Details Regulatory and reimbursement policy issues related to federal healthcare programs, including Medicare and Medicaid. Medicare reimbursement for transformative therapies. H.R. 3, the Lower Drug Cost... |
Celgene Corporation
|
BAKER & HOSTETLER LLP | |||
Details Regulatory and reimbursement policy issues related to federal healthcare programs, including Medicare and Medicaid. |
C.R. Bard Inc.
|
BAKER & HOSTETLER LLP | |||
Details Regulatory and reimbursement policy issues related to federal healthcare programs, including Medicare and Medicaid. |
Pharmaceutical Research and Manufacturers of America
|
BAKER & HOSTETLER LLP | |||
Details Federal regulatory policy issues related to bioidentical hormone replacement therapy. |
Bioidentical Hormone Replacement Therapy Coalition
|
BAKER & HOSTETLER LLP | |||
Details Policy issues related to Public Law 114-225, the 21st Century Cures Act Policy issues related to Public Law 112-144, the Food and Drug Administration Safety and Innovation Act Policy issues relat... |
Prospect Medical Holdings, Inc.
|
BAKER & HOSTETLER LLP | |||
Details Regulatory and reimbursement policy issues related to federal healthcare programs, including Medicare and Medicaid. |
OncoSec Medical Inc.
|
BAKER & HOSTETLER LLP | |||
Details Federal regulatory and reimbursement policies relating to eye care services, medicines and medical technologies. |
Alcon Vision, LLC
|
BAKER & HOSTETLER LLP | |||
Details Support of FFL Protection Act (H.R. 2179, S1788); support of Target Practice and Marksmanship Training Support Act (H.R.1222, S94), support of Project Child Safe education program. Funding for DoJ ... |
National Shooting Sports Foundation, Inc.
|
Mercury Public Affairs, LLC | |||
Details Technology policy issues relating to e-commerce. Policy issues relating to access to U.S. capital markets. |
Alibaba Group Holding Limited
|
BAKER & HOSTETLER LLP | |||
Details Medicaid, CHMGE, and other research and education issues relevant to children's hospitals |
Texas Children's Hospital
|
BAKER & HOSTETLER LLP | |||
Details Medicaid policy issues affecting children's hospitals. S. 428, the "Advancing Care for Exceptional Kids Act". H.R. 5385, the Childrens Hospital GME Support Reauthorization Act. S. 2897, the Child... |
Children's Hospital Association
|
BAKER & HOSTETLER LLP | |||
Details Support for federal arts funding, generally; support for National Endowment for the Arts funding in fiscal year 2024 Support of National Endowment for the Arts funding in fiscal year 2024; Support ... |
INTERNATIONAL ALLIANCE OF THEATRICAL STAGE EMPLOYEES
|
in-house lobbying | |||
Details HR 5580, Saving Our Mainstreet American Locations for Leisure and Shopping Act - ALL S 1706/HR 4721, Main Street Tax Certainty Act - ALL HR 976 TCJA Tax Permanency Act - Sec 111 Deduction for Quali... |
International Council of Shopping Centers
|
in-house lobbying |